Tubidy
COMBI-AD: long-term follow-up of dabrafenib and trametinib in BRAF-mutated melanoma

COMBI-AD: long-term follow-up of dabrafenib and trametinib in BRAF-mutated melanoma

02:51 |
Download MP3

Related Videos

© 2024 Tubidy